The Tg.AC mouse is being evaluated for use in short-term carcinogenicit y bioassays. Because the dermal test protocol necessitates dissolving test agents we determined the effects of several solvents on responsivenes s of hemizygous mice to dermal applications of the classical skin tumor promoter, phorbol 12-myristate 13-acetate (TPA). Mice of both sexes received dermal applications of either acetone (negative control) or TPA in various vehicles [acetone, 100% methanol , 70% and 100% ethanol, DMSO and mixtures of acetone and ethanol (1:1), acetone and DMSO (4:1 and 1:1), and acetone and olive oil (4:1)]. Negative control animals did not exhibit papillomas. When administered in acetone, ethanolic or methanolic vehicles TPA caused prompt and robust papillomatous responses. TPA was also tumorigenic in all nonalcoholi c vehicles, except the acetone-olive oil mixture. Papilloma responses were generally delayed when TPA was applied in the nonalcoholi c solvents but the distinction between TPA-dosed and negative control groups was unequivocal . These results show that choice of vehicle may affect the quantitative and qualitative nature of the response of Tg.AC mice to TPA, but 8 of 9 vehicles proved satisfactory for delivery of TPA.
INTRODUCTION
Genetically altered rodent models have emerged as potentially useful tools in the rapid identi cation and characterization of chemical carcinogens (11, 12) . Transgenic models with possible utility carry genetic variations resulting in either overexpression or inactivation of genes that are fundamental to carcinogenesis but are incapable of independently initiating the neoplastic process. Thus, mice heterozygous for the p53 tumor suppressor gene ( p53 / ) have relatively low incidences of spontaneous tumors but are exquisitely sensitive to the oncogenic effects of mutagenic/genotoxic carcinogens (3, 4, 13) . Tg.AC mice, which carry a v-Ha-ras oncogene fused to the promoter of the f -globin gene (5) , respond to dermal applications of tumor promoters such as phorbol 12-myristate 13-acetate (TPA) with prompt and dose-related development of squamous-cell papillomas of the skin (1, 8, 9) . The Tg.AC model also responds positively to genotoxic chemicals that possess promoting activity, some of which have been shown to be carcinogenic in long-term rodent bioassays (1, 8, 9) .
Tennant et al (11) proposed a means of utilizing transgenic models as adjuncts in the characterization of carcinogenic po-tential. The Tennant approach entails administration of suspect chemicals to Tg.AC and p53 / mice for 26 weeks or until unequivocal tumor responses justify earlier termination of the study. A positive response in both transgenic lines indicates a genotoxic chemical whereas a positive response in only the Tg.AC line is indicative of a non-mutagenic chemical that may cause cancer through an epigenetic mechanism. Negative results in both transgenic lines indicate probable lack of carcinogenic activity.
The Tennant approach is visualized as a means of quickly and unequivocally identifying carcinogens, and of reducing dependence on the 2-year bioassay, thereby conserving human, animal, physical, and nancial resources.
Before any new methodology can be implemented for general use in the scienti c-regulatory community, it must be objectively evaluated and optimized. Critical and impartial evaluation of the predictive utility of transgenic rodent models is underway, and unequivocal de nition of their strengths and weaknesses requires a thoughtful and concerted effort on the part of the scienti c community (10, 13) . To this end, the Department of Toxicology and Safety Assessment at Boehringer Ingelheim Pharmaceuticals has committed to taking part in the International Life Sciences Institute's collaborative effort (6) by conducting studies to optimize experimental protocols and to validate the overall predictive value of transgenic models.
The objective of the study reported in this communication was to weigh the in uence of vehicle composition 535 0192-6233/01$3.00 $0.00 536 STOLL ET AL TOXICOLOGIC PATHOLOGY on the proliferative effect of dermally administered phorbol 12-myristate 13-acetate (TPA) in Tg.AC mice. The effects of TPA administered in acetone are well-de ned because acetone has been the principle vehicle for this mouse skin tumorpromoting agent for decades and it has been the solvent of choice for the use of TPA as a positive control agent in experiments with Tg.AC mice (13) . Ethanol and DMSO have been reported to have inhibitory effects on the responsiveness of dimethylbenz(a)anthracene (DMB)-initiated Sencar mice to topically administered TPA (7), yet little is known about the use of these solvents as TPA vehicles for delivery to Tg.AC mice. Because use of these and other solvents will likely be necessitated in future studies conducted with transgenic models, a systematic characterization of the effects of a variety of solvents on responsiveness of Tg.AC mice to TPA is warranted.
MATERIALS AND METHODS Tennant et al (13) published a basic protocol for the conduct of topical application studies in Tg.AC mice. Our assessment of the in uence of vehicles on the tumorigenicity of TPA in mice was conducted in general compliance with that protocol except that hemizygous rather than homozygous Tg.AC mice were used. These studies were conducted in compliance with established principles of good laboratory practices.
Animals and Animal Husbandry:
Male and female FVB/N Tg.AC mice, hemizygous for the v-Ha-ras oncogene fused to the promoter sequence of the f -globin gene, were received from Taconic Farms Inc (Germantown, NY) on July 7, 1999. To verify the phenotype of the mice, each was proven to be a carrier of the responder genotype by use of the Southern blot hybridization of genomic DNA with a f -globulin probe (14) . Mice were 6-7 weeks of age when received and 8-9-weeks-old at initiation of dosing.
Mice were uniquely identi ed with a BioMedic IMI microchip implanted subcutaneously in the dorsal region of the neck then individually housed in polycarbonate shoeboxstyle cages with fresh Alpha-dri R (Shephard Specialty Paper, Kalamazoo, MI) bedding changed at least twice weekly. Animal room conditions included a 12-hour light-dark cycle and controlled temperature (72 5 F) and humidity (50 20%). Mice had free access to pelleted rodent chow (PMI Feed No 5002, PMI Feeds, Inc, Brentwood, MO) and municipal water delivered via an automatic watering system. Table 1 , were protected from light, stored at 20 C and allowed to reach room temperature before use. TPA concentrations were con rmed by HPLC analysis of solutions used during the 1st, 13th, and nal weeks. Neat acetone served as the negative control solution.
The dose of TPA was selected on the basis of earlier experiments conducted in our laboratories. In our experience, 2.5 l g/mouse of TPA administered three times per week consistently produces an unequivocally positive response in Tg.AC mice. Skin papillomas generally arise within 5-8 weeks and mice usually exhibit multiple ( > 20) tumors. Although this dose of TPA occasionally causes evidence of dermal toxicity, characterized by open wounds and scabbing at the site of repeated applications, we employ it to facilitate a maximal papillomatous response.
One week prior to initiation of dosing, mice were randomly assigned to experimental groups of 15 males and 15 females. An approximately 8-cm 2 area on the back of each mouse was shaved with shaving being repeated as needed except when precluded by the number or size of skin masses in the dose application area. TPA solutions were applied to the backs of mice 3 days per week for up to 26 weeks.
Data Collection: Mice were observed for morbidity and mortality twice daily, 7 days per week. Food consumption, body weights, clinical signs, palpable masses, and the appearance of papillomas in the area of TPA administration were recorded weekly. Papillomas were de ned as being 3-dimensional with a minimum size of 1 1 1 mm. Because some cutaneous masses on Tg.AC mice regress, only lesions that persisted for at least 3 consecutive weeks were recorded. Single dermal papillomas are known to occasionally arise on untreated or negative control Tg.AC mice so only mice with 2 or more skin masses were considered to be positive responders. As skin tumor multiplicity develops the lesions frequently coalesce and become dif cult to differentiate, so we employed an arbitrary upper limit of 20 for the number of papillomas recorded per animal.
It has been our experience that Tg.AC mice dosed 3 times a week with 2.5 l g of TPA in acetone may exhibit skin tumors within 6 weeks. Consequently, we consider dosed animals that survive for 6 weeks to be at-risk for tumor development. Animals that died without tumors before experimental week 6 were purged from the results.
Mice administered the 2.5 l g-dose of TPA in acetone, ethanol (100 or 70%), methanol or acetone/ethanol had nearly maximal tumor responses after 20 weeks and because several of the animals in these groups had open skin lesions the groups were sacri ced. At the scheduled study sacri cing time (27 weeks after initial TPA application), all surviving animals in the remaining groups were sacri ced and subjected to necropsy. Approximately 45 organ and tissue samples, gross lesions, and the identi cation transponder
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RESULTS

Survival, Clinical Signs and Body Weights:
All experimental groups had 14-15 animals surviving after 6 weeks of dosing. Thus, at least 93% of the animals that began the study were considered to have been at risk for skin tumor development. Survival ratios at the times of termination of TPA-dosed groups ranged from 11 to 15/15 (Table 2) .
Grossly observable signs were similar in male and female groups. Skin swelling at the application site, dermal scabbing, and the presence of open skin wounds were observed in all groups of tumor-bearing animals, but these signs were particularly prominent in animals dosed with TPA in acetone, and the alcoholic vehicles. The extent of these lesions prompted early sacri ce (after 20 weeks) of mice administered TPA in acetone, methanol, 70 or 100% ethanol, and in the acetoneethanol mixture. Early sacri cing of these groups had no impact on the interpretation of results because more than 90% of animals that survived through week 20 had more than 20 tumors at the site of TPA application. Skin lesions were not observed in mice dosed with TPA in the olive-oil-containing vehicle.
FIGURE 1.-Papillomatous responses of male and female hemizygou s Tg.AC mice to TPA (2.5 l g/dose) administered 3 times/week in acetone or alcoholic vehicles. Responses were unaffected by sex, so data from males and females were combined. The ranges of tumors/animals at risk are given in the gure. All groups were sacri ced after 20 weeks on study.
All animals gained weight during the experiment and mean gains by females dosed with TPA in 100% ethanol or acetone/ethanol vehicles were signi cantly greater than those of the negative control group ( p < 0.05). These differences were probably secondary to increased food consumption. Animals dosed with TPA in the alcoholic vehicles tended to consume more food than either controls or animals dosed with the nonalcoholic vehicles. The onset of increased food consumption appeared to be coincidental with increasing skin tumor burden.
Skin Tumor Responses to TPA Applied in a Variety of Vehicles:
The overall incidences of skin tumors observed at TPA application sites on Tg.AC mice are summarized in Table 2 and the temporal aspects of tumor development are depicted in Figures 1 and 2 . With the exception of groups dosed with TPA in the DMSO/acetone mixtures, sex had no apparent in uence on experimental results so the data for the sexes were combined for inclusion in the gures. In the case of the DMSO/acetone vehicles, males were generally more responsive than females. With the negative control groups, a single male was observed to have one skin tumor, which appeared during week 22 and persisted through the nal 4 weeks of the experiment, and no females had skin tumors. Because none of the negative control animals were considered TPA responders, they are not represented in the gures. VEHICLE AND DERMAL RESPONSES TO TPA 539 FIGURE 2.-Papillomatous responses of male and female hemizygous Tg.AC mice to TPA (2.5 l g/dose) administered 3 times/week in acetone, DMSO, or acetone/DMSO mixtures. Although males dosed with acetone/DMSO mixtures appeared to be more responsive than females (Table 2) , data for the sexes were combined for graphical presentation. The ranges of tumors/animal at risk are given in the gure. The TPA in acetone group was terminated after 20 weeks.
Administration of TPA in acetone caused prompt and nearly maximal tumor responses in 93 and 100% of males and females, respectively. The mean time to the initial tumor was 7 weeks and tumor multiplicity was nearly maximal by 9 weeks (Table 2) . Administration of TPA in ethanol (either 100 or 70%), methanol, or acetone/ethanol (1:1) also resulted in prompt and robust tumor responses 87-100% of the animals in these groups had multiple papillomas (Figure 1 ). Initial tumor onset times with the alcoholic vehicles were similar to those observed with the acetone (Table 2 ) and tumor multiplicity in these groups was nearly maximal. Although the mean time to achieve maximal tumor yield was somewhat longer in the ethanol, methanol, and acetone/ethanol groups than in the acetone group, maximal tumor yield was always reached well in advance of the scheduled termination of the experiment at 26 weeks.
The use of DMSO, either alone or in combination with acetone, as the TPA vehicle reduced but did not prevent the development of dermal papillomas. Similar papillomatous responses were observed in groups dosed with TPA in DMSO alone or in the 1:1 acetone/DMSO mixture with 80% of males and 40-67% of females exhibiting multiple tumors in the area of TPA application. Fewer animals (13-40%) had multiple skin tumors when dosed with TPA in the 4:1 acetone/DMSO mixture. Neat DMSO and DMSO containing vehicles were also associated with a wider range of tumors per affected animal, ranging from 2 to 20 as compared to 19 to > 20 in animals dosed with TPA in acetone or the alcoholic vehicles (Figure 2) .
The acetone/olive oil (4:1) vehicle was inhibitory to the oncogenic effects of TPA. All animals exposed to this vehicle survived for longer than 20 weeks (1 male and 1 female died during week 20 and a second female died during week 25). One male had 2 tumors, and 4 males and 4 females each had single tumors.
DISCUSSION
Under the conditions of these experiments in Tg.AC mice, ethanol (70 and 100%), methanol, and the 1:1 mixture of acetone and ethanol were nearly indistinguishable from the traditional TPA vehicle, acetone. Thrice weekly applications of 2.5 l g of TPA in any of those vehicles caused prompt (7 weeks) and maximal (usually > 20 papillomas/mouse) tumor responses in 87-100% of the animals tested. The rate of development of the fully expressed tumor response was somewhat slower in mice dosed with TPA in alcoholic vehicles than in animals dosed with TPA in acetone.
Slaga and Fischer (7) reported that use of ethanol as a solvent for TPA reduced the papillomatous responses of DMBA initiated Sencar mice to twice weekly applications of either 1 or 5 l g of TPA. Despite the reduced responsiveness in those experiments TPA caused unequivocal increases in the numbers of papillomas per mouse and the percent of tested animals exhibiting papillomas. Differences between the results of our and the earlier experiments could be related to the model, transgenic vs chemically initiated animals, or dosage regimens, twice weekly vs thrice weekly administrtion. Perhaps the somewhat slower development of the maximal response in our experiment re ects to some extent the inhibitory effect of ethanol noted by Slaga and Fischer (7). Despite these small differences it is clear that ethanol, 540 STOLL ET AL TOXICOLOGIC PATHOLOGY methanol, and mixtures of acetone and ethanol should nd utility as alternative solvents for drugs and chemicals under investigation in the Tg.AC model. Use of neat DMSO as the solvent reduced and delayed but did not mask the papillomatous response of Tg.AC mice to TPA. The response attenuations observed in our experiments are similar to but less striking than those reported earlier in DMBA-initiated Sencar mice (7) . In the earlier experiments, neat DMSO essentially obliterated the response of mice to 1 l g TPA and reduced the response to 5 l g by nearly 80%. In our hands neat DMSO reduced the number of papillomas per affected animal, by 50 to 66% in male and female Tg.AC mice, respectively. Solvents comprised of mixtures of DMSO and acetone also slowed the onset and reduced the magnitude of response of affected Tg.AC mice to TPA and this reduced responsiveness was more pronounced in females than in males.
Although neat DMSO and its combinations with acetone somewhat reduced the response of Tg.AC mice to TPA, these vehicles also could nd utility for solubilizing some test agents for assay in the model. Whereas the tumor response of mice dosed with TPA in acetone/DMSO (4:1) was clearly blunted relative to animals dosed with TPA in neat acetone, the percent of animals with more than single skin tumors and the tumor multiplicity in affected animals clearly differentiated the TPA group from the negative controls.
The mechanism through which DMSO reduces TPA tumorigenicity is unknown. It is possible that DMSO facilitates the penetration of TPA through mouse skin thereby reducing the duration or extent of interaction of the proliferator with follicular elements necessary for papilloma formation. Facilitated penetration of TPA could result in systemic toxicity but mice dosed with DMSO-containing vehicles exhibited no clinical signs that could be attributed to systemic effects of the proliferator. Similarly, necropsy of mice revealed no grossly observable evidence of target organ toxicity. Microscopic examination of tissues remains to be conducted.
Use of olive oil as a TPA vehicle or vehicle component appears unfeasible. Animals receiving TPA in the acetone/olive oil mixture were relatively nonresponsive to TPA with a single male having 2 papillomas (with the second appearing during week 25) and 4 males and 4 females having only 1 mass each. Perhaps olive oil forms a protective coating in the area of application thereby preventing interaction between TPA and the target follicular epithelial cells (2) of the skin.
The results of this study show that choice of vehicle may affect the qualitative or quantitative nature of the response of Tg.AC mice to TPA. Despite the demonstrated variations in responsiveness to TPA administered in the various mediums, 8 of the 9 vehicles tested proved satisfactory for the delivery of the positive control agent. With the singular excpetion of acetone/olive oil, responses of animals to TPA administered in each of the vehicles were unequivocal in demonstrating the proliferative effects of the positive control agent. Even when administered in the acetone/DMSO (4:1) vehicle, when compared to the negative control group with respect to either percent of animals responding or the numbers of tumors per affected animal or animals at risk, TPA was unambiguously tumorigenic.
As new solvent systems for test agents in the Tg.AC model are identi ed, it is likely that some will attenuate, whereas others will promote the papilloma response. Investigators wishing to employ solvents other than acetone, ethanol, or methanol as vehicles should plan to conduct preliminary experiments to characterize the interaction between the solvent and TPA in order to facilitate interpretation of data.
